A fresh discovery at Spur has put the Lachlan Fold Belt back in play, with juniors scrambling to prove up the next big hit.

Rhythm Biosciences (ASX:RHY) vision is starting to take flight as Pitt Street values Rhythm at more than double its current ...

After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the commercial rollout is gaining traction.

The ASX is taking its chances with Trump’s 5-day pause in Iran, piling back in on the first hint the conflict could be nearing an end.

Biotech catches a break, with Amplia’s trial results lifting sentiment as psychedelics edge further into the mainstream.

From virtual fences which use collars to keep livestock away from boundaries, to a new standard for scoring the quality of ...

Killi set to gain impetus after hiring mining industry top guns ; Approval granted to Felix for bulk sampling at NW Array in ...

Mineral potential and a 'tough but fair' stance on new digs has snared South Australia top spot in a global investment report ...

Cash yields have improved, but with inflation lingering and rate cuts delayed, investors risk mistaking stability for real ...

The ASX has slipped into correction territory as metals slump, oil surges and fresh geopolitical tensions rattle early trade ...

Regener8 Resources’ Srebrenica North is essentially unexplored despite its mining history while operating mines next door add ...

The market has staved off the worst of its losses, bouncing off session lows of almost -2pc as 5 sectors enter bear markets.